myoscience’s PCP 1.0 system, intended for use in the physician’s office, delivers cold energy to targeted nerves, according to the company.
The device previously received CE approval and a medical device license from Health Canada.
“FDA clearance for our device in the United States provides myoscience with a platform technology on which to grow our company by addressing further indications and an expanding geography,” said Clint Carnell, CEO of myoscience, in the release.
myoscience is headquartered in Redwood City, Calif.
Related Articles on FDA Clearances:
Cook Medical Received FDA Clearance for Colonic Controlled-Release Stent
BD Diagnostics Received FDA Clearance for MRSA Test
r4 Vascular Receives FDA Clearance for PTA Balloon
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.